A portfolio of high quality, innovative companies
Portfolio
Corteria Pharmaceuticals
Corteria is developing first in class and best in class programs for heart failure, obesity and autosomal dominant polycystic kidney disease.
Corteria Pharmaceuticals Website
MC Sciences
MC Sciences is a company developing first-in-class therapies for mast cell related-diseases.
MC Sciences Website
GlycoEra
GlycoEra AG is a biotechnology company dedicated to developing best-in-class protein degraders to transform the treatment of autoimmune diseases.
GlycoEra Website
Tribune Therapeutics
Novel medicines to treat fibrosis no matter the cause Inspired by nature. Fueled by insight.
Tribune Therapeutics Website
Fluid Biomed
Fluid Biomed is commercializing the first polymer-based brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke.
Fluid Biomed Website
Cytospire Therapeutics
Cytospire is developing an innovative portfolio of differentiated multispecific engager antibodies to enhance and direct the activity of innate and adaptive effector immune cells.
Cytospire Therapeutics Website
T-Cypher Bio
At T-Cypher Bio we generate TCR-based therapeutics that have the potential to transform the treatment of solid tumours, autoimmune, inflammatory, and infectious diseases.
T-Cypher Bio Website
Function RX
Function RX is a company developing therapies for neurodegeneration.
Function RX Website
Affect Therapeutics
Affect Therapeutics is a team of passionate people who are changing the way the world treats addiction.
Affect Therapeutics Website
HillStar Bio
Hillstar aspires to build a portfolio of programs against autoimmune diseases with unmet or underserved medical needs.
HillStar Bio Website
OZLO Sleep
Better sleep streams here. Meet the next-gen streaming Sleepbuds® you've been dreaming about. These tiny, exceptionally comfortable wireless headphones have been specifically designed for all-night comfort, so you can sleep soundly. Sleepbuds® have been clinically validated to help you fall asleep. With biometric sensors for insights about your sleep and results-driven solutions.
OZLO Sleep Website
Climb Bio
Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. Our lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases.
Climb Bio Website
Maxion Therapeutics
Maxion Therapeutics Website
RQ BIO
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) against seasonal influenza
RQ BIO Website
AviadoBio
Developing transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders
AviadoBio Website
Pheno Therapeutics
Discovering and developing small molecules to promote remyelination to treat multiple sclerosis
Pheno Therapeutics Website
Ikarovec
Developing novel, differentiated gene therapies for eye conditions, including diabetic macular oedema, age-related macular degeneration (AMD) and intra-ocular hypertension
Ikarovec Website
Cumulus Neuroscience
Their next-generation integrated physiological and digital biomarker platform can monitor diseases of the central nervous system at home – providing feedback on disease progression and response to treatment
Cumulus Neuroscience Website
LifeArc had the vision to support RQ Bio from the very beginning and as a direct result new innovative antibodies were discovered to potentially protect vulnerable patients from Covid. In addition, a company was also born that will develop medicines to provide instant and long-lasting protection for vulnerable people at risk of severe disease or death from a multitude of viral infections. Both as major shareholder and a scientific partner, LifeArc continues to support and collaborate with RQ Bio so that the public health, medical and patient impact of our innovation can be maximised.